Medical information Clinical review pending

Infection Testing

Cytomegalovirus CMV Antibodies Panel IgG IgM Test

This test detects antibodies to Cytomegalovirus (CMV), a common virus that can cause serious illness in pregnant women and those with weakened immune systems. It measures both recent (IgM) and past (IgG) infections.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample.
Results: Confirm with the laboratory before booking.
Preparation: No special preparation is required for this test. However, confirm with the laboratory before booking.

Test priceKSh 2,340

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Cytomegalovirus CMV Antibodies Panel IgG IgM Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Pregnant women concerned about CMV transmission
✓Individuals with weakened immune systems (e.g., transplant recipients, chemotherapy patients)
✓People experiencing symptoms suggestive of CMV infection (fever, fatigue, swollen glands)
✓Monitoring CMV status in high-risk populations
✓Evaluating potential congenital CMV infection in newborns

In plain language

What this test helps you understand

This test helps diagnose current or past CMV infection, assess risk during pregnancy, and guide management in immunocompromised individuals.

The Cytomegalovirus (CMV) Antibodies Panel IgG and IgM Test is used to identify antibodies against CMV in your blood. CMV is a widespread virus that usually causes mild or no symptoms in healthy people, but it can lead to significant health problems in pregnant women, newborns, and individuals with compromised immune systems. This test helps determine if you have a current or past CMV infection.

This test measures two types of antibodies:

* **IgM antibodies:** These typically appear early after a new infection and suggest a recent CMV infection. * **IgG antibodies:** These develop later and can persist for life, indicating a past infection or immunity to CMV.

By measuring both IgG and IgM, healthcare providers can gain a clearer picture of your CMV status, which is important for managing potential risks, especially during pregnancy or if you have a weakened immune system.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo special preparation is required for this test. However, confirm with the laboratory before booking.

SampleBlood sample.

MethodologyImmunoassay (e.g., ELISA or Chemiluminescence) to detect and quantify CMV IgG and IgM antibodies.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

Antibody levels can vary. A positive result indicates exposure but doesn't always confirm active disease. Interpretation requires clinical correlation. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

CMV is a common virus that most people are exposed to at some point. It usually causes mild or no symptoms in healthy individuals but can be serious for pregnant women, newborns, and people with weakened immune systems.

CMV infection during pregnancy can potentially harm the developing baby. This test helps assess the risk of transmission and allows for appropriate monitoring and management.

IgM antibodies usually indicate a recent or current infection. IgG antibodies suggest a past infection or immunity. The combination helps determine the timing and status of the infection.

No special preparation, such as fasting, is typically required for this blood test. However, it's always best to confirm specific instructions with the laboratory before your appointment.

A healthcare provider will interpret the results based on your individual clinical situation, including symptoms and medical history. They will explain what the results mean for you.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp